HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lígia C Gomes-da-Silva Selected Research

Carcinoma (Carcinomatosis)

1/2023Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming.
9/2015Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens.
6/2013Impact of PLK-1 silencing on endothelial cells and cancer cells of diverse histological origin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lígia C Gomes-da-Silva Research Topics

Disease

20Neoplasms (Cancer)
10/2023 - 07/2012
3Carcinoma (Carcinomatosis)
01/2023 - 06/2013
3Breast Neoplasms (Breast Cancer)
11/2015 - 09/2012
2Triple Negative Breast Neoplasms
10/2023 - 11/2015
2Melanoma (Melanoma, Malignant)
01/2023 - 12/2014
2Phototoxic Dermatitis (Phototoxicity)
01/2022 - 01/2016
2Neoplasm Metastasis (Metastasis)
12/2019 - 09/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2020
1Cystic Fibrosis (Mucoviscidosis)
11/2019
1Infections
11/2019
1Adenocarcinoma of Lung
01/2016
1Colonic Neoplasms (Colon Cancer)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
11/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013

Drug/Important Bio-Agent (IBA)

101-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2023 - 09/2015
5Photosensitizing Agents (Photosensitizers)IBA
10/2023 - 01/2016
5Small Interfering RNA (siRNA)IBA
11/2013 - 07/2012
4redaporfinIBA
01/2023 - 01/2016
4Messenger RNA (mRNA)IBA
01/2018 - 09/2012
4Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2012
4Liposomes (Liposome)IBA
11/2015 - 09/2012
3Peptides (Polypeptides)IBA
10/2018 - 09/2012
2HydrogelsIBA
10/2023 - 11/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2016
2Oxygen (Dioxygen)IBA
11/2020 - 01/2016
2AntigensIBA
10/2018 - 01/2018
2Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 06/2013
2LipidsIBA
09/2012 - 07/2012
1AzidesIBA
10/2023
1temoporfinIBA
10/2023
1pyridineIBA
10/2023
1chlorinIBA
10/2023
113(1)-(2'-(2-pyridyl)ethylamine) chlorin e6IBA
10/2023
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1TetrapyrrolesIBA
01/2022
1SulfonamidesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
11/2020
1LigandsIBA
11/2020
1Cetuximab (Erbitux)FDA Link
10/2020
1ChloridesIBA
11/2019
1Chloride Channels (Chloride Channel)IBA
11/2019
1squaramideIBA
11/2019
1PeptidomimeticsIBA
10/2018
1AnthracyclinesIBA
01/2018
1X-Box Binding Protein 1IBA
01/2018
1CalreticulinIBA
01/2018
1Activating Transcription Factor 4IBA
01/2018
1Activating Transcription Factor 6IBA
01/2018
1AntioxidantsIBA
01/2016
1EnzymesIBA
01/2016
1Superoxide DismutaseIBA
01/2016
1PlasticsIBA
11/2015
1Drug CombinationsIBA
11/2015
1NucleolinIBA
11/2015
1bacteriochlorinIBA
09/2015
1CeramidesIBA
12/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014
1Phosphotransferases (Kinase)IBA
06/2013
1enhanced green fluorescent proteinIBA
09/2012

Therapy/Procedure

10Photochemotherapy (Photodynamic Therapy)
10/2023 - 09/2015
2Therapeutics
10/2023 - 07/2012
2Intravenous Injections
10/2020 - 09/2015
2Drug Therapy (Chemotherapy)
11/2015 - 11/2013
1Injections
10/2023